Clinical trial
Procalcitonin and the Inflammatory Response to Salt in Essential Hypertension: a Randomised Cross-over Clinical Trial.
NCT01665534 is registered in ClinicalTrials.gov with Carmine Zoccali as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin and the Inflammatory Response to Salt in Essential Hypertension: a Randomised Cross-over Clinical Trial.
- Lead sponsor
- Carmine Zoccali
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- March 31, 2011
- Enrollment
- 32 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
essential hypertension.